Skip to main content
Caplight Logo









Vivodyne

Vivodyne

Private
Philadelphia, PennsylvaniaHealthcare & Life Scienceshttps://www.vivodyne.com/

Last Round

Series A

May 29, 2025

Total Funding Raised

$82M

Momentum

Top 10%

of companies Caplight tracks

Company Overview

Vivodyne is a biotechnology company that develops a microfluidic bioengineering platform for advancing single-cell 4D phenomics and facilitating drug discovery and cellular therapies.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials, Biotech Equipment

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Application

Keywords

organoiddrug discoveryanimal testing alternativelab-grown human tissuepreclinical drug developmentorgan-on-a-chipautomated drug testinghuman physiological dataclinical trial successAI-driven biologyin vitro testinghigh-throughput screeningpredictive toxicologybio-simulationdigital twin biology

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Vivodyne Comparables

Compare Vivodyne with similar companies based on industry and business-model similarity.

Vivodyne comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Quris AI
86%
Emulate
85%
Hesperos Inc.
85%

Vivodyne Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AMay 29, 2025
SeedNov 22, 2023
SeedMar 30, 2021

Key People

Founding team and executive leadership

Andrei Georgescu

Chief Executive Officer

Executive Team

Vivodyne Investors

Notable investors and investment history

Vivodyne investors
InvestorRounds
LingottoSeries A
Khosla VenturesSeries A, Seed
Kairos VenturesSeries A, Seed
Helena CapitalSeries A
Helena Special InvestmentsSeries A
Fortius VenturesSeries A
CS VenturesSeries A, Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 24, 2026

    Monthly visitors increased 48% MoM to 3.9K.

  • Apr 1, 2026

    Partnered with a majority of top 10 multinational pharmaceutical companies.

Recent news

Latest coverage and updates

  • launchesAug 25, 2026

    Vivodyne launches Series 2 TissueDisk.

  • invests_into_assetsAug 19, 2026

    Vivodyne invested into assets: human data center in the amount of $80M on Aug 1st '26.

  • receives_financingAug 19, 2026

    Vivodyne received financing of $80M on Aug 1st '26.

  • is_developingAug 18, 2026

    Vivodyne is developing automated system on Aug 18th '26.

  • launchesAug 12, 2026

    Vivodyne launched world's largest human biological datacenter on Aug 12th '26.

Vivodyne Filings

Explore SEC and related filing metadata, where available.

Vivodyne filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Vivodyne's valuation, stock price, and market status.

Is Vivodyne a public or private company?

Vivodyne is a private company.

What is the current stock price of Vivodyne?

Vivodyne is a private company with no public stock price. No recent secondary market data is available.

How much is Vivodyne worth (valuation)?

Valuation information for Vivodyne is not publicly available.

Can I buy Vivodyne stock?

Vivodyne shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Vivodyne's last funding round?

Vivodyne's most recent funding round was Series A on May 29, 2025.

Who are the main investors in Vivodyne?

Key investors in Vivodyne include Khosla Ventures, Kairos Ventures.

Will Vivodyne IPO soon?

No public IPO plans have been announced for Vivodyne.

How can I track Vivodyne secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Vivodyne's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersPhiladelphia, Pennsylvania
Employee Range38
Year Founded2020
Last FundingMay 29, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?